We are live on ! Find out more
C

Covestor Portfolio holdings

AUM $173M
1-Year Est. Return 56.91%
This Fund
S&P 500
This Quarter Est. Return
-1.81%
1 Year Est. Return
+56.91%
3 Year Est. Return
+135.94%
5 Year Est. Return
10 Year Est. Return
AUM
$150M
AUM Growth
+$78.9M
Cap. Flow
+$77M
Cap. Flow %
51.23%
Top 10 Hldgs %
11.72%
Holding
2,587
New
209
Increased
1,414
Reduced
734
Closed
129

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$3.85M
2
JOE icon
St. Joe Company
JOE
+$1.25M
3
SSO icon
ProShares Ultra S&P500
SSO
+$1.06M
4
HPE icon
Hewlett Packard
HPE
+$855K
5
DXC icon
DXC Technology
DXC
+$816K

Sector Composition

Rank Sector Weight
1 Technology 15.4%
2 Consumer Discretionary 14.05%
3 Industrials 11.01%
4 Financials 10.93%
5 Miscellaneous 10.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAMP icon
2376
LiveRamp
RAMP
$2.29B
$0 ﹤0.01%
11
-3
-21% -$125
RAPT
2377
DELISTED
RAPT Therapeutics
RAPT
$0 ﹤0.01%
+1
New +$189
RC
2378
Ready Capital
RC
$271M
$0 ﹤0.01%
20
-5
-20% -$75
RCKT icon
2379
Rocket Pharmaceuticals
RCKT
$368M
$0 ﹤0.01%
13
-4
-24% -$69
RCUS icon
2380
Arcus Biosciences
RCUS
$3.13B
$0 ﹤0.01%
13
-4
-24% -$134
RDFN
2381
DELISTED
Redfin
RDFN
$0 ﹤0.01%
14
-90
-87% -$2.32K
RDNT icon
2382
RadNet
RDNT
$5.94B
$0 ﹤0.01%
16
-144
-90% -$3.52K
REAL icon
2383
The RealReal
REAL
$1.2B
-25
Closed
REPL icon
2384
Replimune Group
REPL
$1.22B
$0 ﹤0.01%
13
-3
-19% -$57
RES icon
2385
RPC Inc
RES
$1.43B
-1
Closed
RGNX icon
2386
Regenxbio
RGNX
$563M
$0 ﹤0.01%
9
-2
-18% -$56
RIVN icon
2387
Rivian
RIVN
$23.2B
$0 ﹤0.01%
+6
New +$365
RLAY icon
2388
Relay Therapeutics
RLAY
$4.14B
$0 ﹤0.01%
15
-4
-21% -$97
RLJ icon
2389
RLJ Lodging Trust
RLJ
$1.66B
$0 ﹤0.01%
31
-8
-21% -$113
RMAX
2390
DELISTED
RE/MAX Holdings
RMAX
-21
Closed -$1K
RMR icon
2391
The RMR Group
RMR
$325M
$0 ﹤0.01%
1
-1
-50% -$31
RNST icon
2392
Renasant Corp
RNST
$3.73B
$0 ﹤0.01%
14
-33
-70% -$1.21K
ROAD icon
2393
Construction Partners
ROAD
$5.66B
$0 ﹤0.01%
8
-3
-27% -$79
RPAY icon
2394
Repay Holdings
RPAY
$295M
$0 ﹤0.01%
19
-5
-21% -$83
RSI icon
2395
Rush Street Interactive
RSI
$3.06B
-20
Closed
RVMD icon
2396
Revolution Medicines
RVMD
$43.7B
$0 ﹤0.01%
13
-4
-24% -$87
RVLV icon
2397
Revolve Group
RVLV
$1.5B
$0 ﹤0.01%
6
-1
-14% -$51
RWT
2398
Redwood Trust
RWT
$446M
$0 ﹤0.01%
32
-8
-20% -$91
RXRX icon
2399
Recursion Pharmaceuticals
RXRX
$1.72B
$0 ﹤0.01%
25
-7
-22% -$74
RXT icon
2400
Rackspace Technology
RXT
$821M
$0 ﹤0.01%
30
-7
-19% -$83

Similar funds

Covestor's Q1 2022 Portfolio in Review

As of Q1 2022, Covestor held 2,587 positions worth $150M, up 111% from $71.4M the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Covestor deployed $77M of net new capital in Q1 2022, opening 209 new positions and adding to 1,414 existing holdings. Its largest new stake was ProShares Ultra S&P500: 33,080 shares worth $1.08M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 19% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Sempra, an estimated $85.9K trimmed.

  • Covestor's largest Q1 2022 buy was ProShares Ultra S&P500: 33,080 shares worth $1.08M.
  • Covestor added most to Tesla in Q1 2022, an estimated $3.85M increase.
  • Covestor's biggest Q1 2022 reduction was Sempra, cutting an estimated $85.9K.
  • Covestor fully exited Global X Genomics & Biotechnology ETF in Q1 2022, selling an estimated $75K.
  • Covestor's ten largest holdings make up 12% of its $150M portfolio in Q1 2022.
  • Covestor opened 209 new positions and closed 129 in Q1 2022.
  • Covestor's portfolio value rose 111% quarter-over-quarter to $150M.

Based on Covestor's 13F filing for Q1 2022, filed 13 May 2022.